A Better Solution for Addiction Care Providers
Discover Spark's Multi-path Neurostimulation solutions to treat opioid withdrawal.

Flexible, Drug-Free Therapy, Better Patient Outcomes
Whether transitioning patients to MAT/MOUD or eliminating opioids from daily life, managing opioid withdrawal is a pivotal first step. It’s a critical moment - a chance to stabilize patients in withdrawal or risk losing them to an AMA discharge. Studies show approximately 10% of patients leave against medical advice in the first three days of treatment – many due to unmanaged withdrawal.
Spark Multi-path Neurostimulation treatments with the wearable Sparrow Ascent device are a better way forward for rapid and sustainable withdrawal management.
Sparrow Ascent - Multi-path Neurostimulation for Addiction Management
Sparrow Ascent changes the way opioid withdrawal is managed, using a non-invasive, FDA-cleared solution that directly targets withdrawal symptoms without drug interactions or systemic side effects.
Indication for Use: The Sparrow Ascent is a transcutaneous nerve field stimulator for patients experiencing opioid withdrawal in conjunction with standard symptomatic medication and other therapies for opioid withdrawal symptoms. Treatments are applied under the supervision of trained clinical personnel.
Transcutaneous Auricular Neurostimulation (tAN®) FDA-cleared, prescription, wearable neurostimulation for opioid withdrawal relief.

A Better Solution for All Kinds of Care Providers
Spark Multi-path Neurostimulation is a proven solution for a range of addiction disorder treatment providers.

State Hospitals and Care Providers
Veterans Affairs Health Providers


Indian Health Providers
Addiction Treatment Centers


What Makes Sparrow Ascent Different?
As the first FDA-cleared, non-invasive, wearable Multi-path Neurostimulation device for opioid withdrawal relief, Sparrow Ascent delivers:
A Drug-Free/Non-Invasive Option: No systemic side effects, no added medications, no drug interactions, no needles, no surgery.
Rapid Activation: Begins working in as little as 30 minutes; 84% of patients report mild to no symptoms within an hour.
Proven Efficacy: 100% of participants in clinical trials sustained meaningful relief at day three and beyond.
Withdrawal Management - Clinical Advantages
Sparrow Ascent minimizes key obstacles that can cause withdrawal-related treatment disruption.
Reduces Early Discharges
A proven tool that lowers withdrawal-related AMA discharge rate in the first three days.
Optimizes Provider Resources
Reduces high-acuity patient burden on staff with a safe, fast-acting, flexible approach to withdrawal management.
Enhances Ongoing Patient Engagement
90% of patients who completed detox with Sparrow Ascent continued to the next treatment step.
Maximizes Patient Access
Sparrow Ascent can be used across IP, OP, and in-home care settings, allowing unique treatment options not yet offered by other centers.
Results by the Numbers
of participants experienced mild or no withdrawal symptoms after 60 minutes of therapy.
of participants sustained a clinically meaningful reduction in withdrawal symptoms by day three.
participants who completed detox accepted a referral to continue opioid use disorder treatment.
Additional Resources
Explore the latest news from Spark Biomedical and access our library of publications, research, and user testimonials, or visit our Clinical Evidence page here.
To receive information on how Sparrow Ascent fits into your patients' care regimen, complete the form below.
